Transport of Dietary Anti-Inflammatory Peptide, γ-Glutamyl Valine (γ-EV), across the Intestinal Caco-2 Monolayer

Nutrients. 2021 Apr 24;13(5):1448. doi: 10.3390/nu13051448.

Abstract

The present study analyzed the transepithelial transport of the dietary anti-inflammatory peptide, γ-glutamyl valine (γ-EV). γ-EV is naturally found in dry edible beans. Our previous study demonstrated the anti-inflammatory potency of γ-EV against vascular inflammation at a concentration of 1mM, and that it can transport with the apparent permeability coefficient (Papp) of 1.56 × 10-6 ± 0.7 × 10-6 cm/s across the intestinal Caco-2 cells. The purpose of the current study was to explore whether the permeability of the peptide could be enhanced and to elucidate the mechanism of transport of γ-EV across Caco-2 cells. The initial results indicated that γ-EV was nontoxic to the Caco-2 cells up to 5 mM concentration and could be transported across the intestinal cells intact. During apical-to-basolateral transport, a higher peptide dose (5 mM) significantly (p < 0.01) enhanced the transport rate to 2.5 × 10-6 ± 0.6 × 10-6 cm/s. Cytochalasin-D disintegrated the tight-junction proteins of the Caco-2 monolayer and increased the Papp of γ-EV to 4.36 × 10-6 ± 0.16 × 10-6 cm/s (p < 0.001), while theaflavin 3'-gallate and Gly-Sar significantly decreased the Papp (p < 0.05), with wortmannin having no effects on the peptide transport, indicating that the transport route of γ-EV could be via both PepT1-mediated and paracellular.

Keywords: Papp; bioactive peptides; intestinal Caco-2 cells; peptide absorption; peptide transport mechanism; γ-glutamyl peptides.

MeSH terms

  • Anti-Inflammatory Agents / metabolism*
  • Biological Transport
  • Caco-2 Cells
  • Cells, Cultured
  • Dipeptides / metabolism*
  • Humans
  • Intestinal Mucosa / metabolism*
  • Peptides / metabolism

Substances

  • Anti-Inflammatory Agents
  • Dipeptides
  • Peptides
  • gamma-glutamylvaline